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1. INTRODUCTION 
Traumatic deaths contribute to more years of life lost globally compared to cancer 
and cardiac related deaths combined (Trunkey 1983). It is estimated, that after 
every six seconds someone deceases secondary to an injury accounting for more 
than five million trauma related deaths every year exceeding even fatalities 
secondary to HIV, tuberculosis and malaria (WHO 2015) (Figure 1). 
Unintentional injuries are the leading cause of death in the age group of 1–44 
years. In the age group of 15–34 years, unintentional injuries, homicides, and 
suicides are the top three causes of death (CDC 2017). Likewise, the economic 
burden of injury to society is staggering as a significant proportion of patients are 
contributing to economic revenues while they suffer permanent disability or 
death due to traumatic insults.  
 
Figure 1. Fatalities secondary to injuries and HIV/AIDS, TB and malaria (WHO, Injuries 
and Violence: the facts, Global burden of disease, 2004). 
 
Injury-related deaths in Estonia are among highest in the European Union per the 
EuroSafe reports comprising 7–11% of all causes of death in recent years in 
Estonia (EuroSafe 2016, EuroSafe 2014, EuroSafe 2013). Thus, injury related 
deaths are significant public health concern locally, regionally and in a global 
perspective. 
ISS is most widely utilized and recognized trauma severity score in a scientific 
literature based on anatomic indices (Baker, et al. 1974). ISS >15 is defined as 
severe trauma and patients with severe injury burden have considerably better 
survival outcomes when treated at designated trauma centers (Demetriades, et al. 
2006).  
Estonia has two designated trauma centers treating most of the severely 
injured patients including NEMC with TCH in the Northern region involving a 
0
1
2
3
4
5
6
7
Injuries HIV/AIDS + tuberculosis +
malaria
Deaths per year (millions)
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catchment area of 25 000 km2 with estimated population of 800 000 inhabitants. 
Tartu University Hospital (TUH) being the referral trauma center in the Southern 
region comprises a population of 500 000 within a 20 000 km2 catchment area. 
Trauma system in Estonia has evolved dramatically since Estonia regained 
independence in 1991 after dissolution of Soviet Union. As an undeveloped 
country, the trauma system was poorly designed and scarcely equipped during 
nineties with a very high rate of violent crime at that time. Nevertheless, Estonian 
trauma system has developed significantly in all aspects with a modern pre-
hospital system accessing to all patients within 30-min time interval, introduction 
of damage control resuscitation and surgery, improved intensive care and 
rehabilitation. Also, the most important trauma courses including ATLS (since 
2015), DSTC & DATC (since 2017) and ASSET (since 2018) have been 
introduced recently (American College of Surgeons 1980, IATSIC 2015, 
American College of Surgeons 2010). 
However, studies involving severely injured patients (ISS >15) in Estonia 
were lacking. Thus, the studies involved in the thesis are the pioneering 
investigations including patients with severe injuries per ISS with comparison of 
time periods, trauma centers, pre-hospital deaths, and with other countries. Also, 
as Estonia is relatively small country with few designated trauma centers and one 
common forensic medicine database autopsy studies with population-based 
perspective are possible.  
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2. REVIEW OF THE LITERATURE 
2.1. Trauma Scorings 
ISS is most widely utilized trauma severity score in a scientific literature based 
on anatomic indices (Baker, et al. 1974) ISS is based on the AIS score, which 
divides injuries to six regions of body: head-neck, face, chest, abdomen, pelvis-
extremities, and body surface (Gennarelli, Wodzin ja Association for the 
Advancement of Automotive Medi 2008). All injuries in every region are 
classified in a six-point scale with higher number correlating with more severe 
injury. To calculate the ISS the highest AIS score in the three most severely 
injured ISS body regions is squared and added for the final ISS score. ISS score 
ranges between 1 and 75 and higher score correlates with higher morbidity and 
mortality. ISS >15 definition of severe trauma is globally accepted and widely 
utilized since 1974 after introduction by Baker and colleagues (Baker, et al. 1974). 
Accordingly, the ISS >25 defines critical injury burden. ISS permits to compare 
outcomes of patients treated at different hospitals or different time periods with 
similar injury burden. However, ISS has some well-known limitations with most 
important being that different injuries in one region are not weighted in. Also, 
ISS is not useful as a triage tool as all injuries must be recognized for calculation 
(TRAUMA.ORG 2006). Nevertheless, despite some weaknesses as with most of 
medical scoring systems the ISS is still extensively used and allows comparison 
between different settings and with former studies. 
The RTS score is another widely utilized trauma scoring based on three first 
measured physiological parameters including GCS, SBP and RR (Champion, 
Sacco ja Carnazzo, et al. 1981, Champion, Sacco ja Copes WS, et al. 1989). RTS 
ranges between 0 and 7.841 with lower score correlating with worse outcomes, 
however, inconsistency of measurement cut-offs of the physiological variables 
and frequently missing variables affects the use of this score for comparison 
between different trauma settings. Nevertheless, the RTS is part of the TRISS 
score, which adds ISS, RTS, patient’s age, and mechanism of injury (blunt or 
penetrating) into a computed based logarithmic equation to calculate probability 
of survival between 0 and 100% (Boyd, Tolson ja Copes 1987). Thus, TRISS 
methodology permits to calculate survival rate for certain cohort of injured 
patients and compare it with actual crude mortality showing if the real outcomes 
are worse or better per prediction. TRISS is relatively easy to use and, thus, has 
been utilized for many decades to compare improvements in time and between 
trauma centers. TRISS methodology is criticized for the simplistic dichotomous 
stratification of age variables and low performance for certain mechanism of 
injuries (Kennedy, Grant ja Blackwell 2001).  
Many new scoring systems have been adopted including NISS or RISC score, 
however, the well-known classical trauma scores ISS, RTS and TRISS persist as 
the globally utilized standardized measures of injury severity (Lefering 2009, 
Lavoie, et al. 2004).  
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2.2. Demographics and Outcomes of patients  
with Injury Severity Score >15 
Overall consensus exists that severely injured patients should be treated at 
designated trauma centers. A large study by Demetriades and co-authors involving 
more than 130 000 patients with ISS >15 noted significantly lower adjusted 
mortality rate at Level I trauma centers in USA compared to lower level or unde-
signated trauma centers (Demetriades, et al. 2006). Per the study by Demetriades 
et al., the overall injury mortality was 14.9% and 16.8% at Level I centers and 
lower level or undesignated trauma centers, respectively. Penetrating trauma 
accounted 11.2% of cases and every third patient (33.2%) was critically injured.  
In the European setting, the outcomes are variable across the regions. A study 
from Switzerland showed relatively high overall mortality at 26.2% (Heim, et al. 
2014). Most frequent mechanism of injuries was traffic accidents and falls from 
height. Blunt trauma accounted for 91.2% of the cases. A study by Nijboer et al. 
from Netherlands showed overall severe trauma mortality of 25% (Nijboer, et al. 
2007). Other study from Bologna region in Italy noted 17.2% rate of severe 
trauma mortality with significant decrease in time being 25.8% in 1996 and 
10.3% in 2004 (DiSaverio, et al. 2014). TBI accounted for most of the deaths at 
58.4% followed by hemorrhage at 28.4%. Blunt trauma occurred in 97.1% of 
patients. A study based on the Germany trauma registry DGU reported 19.7% 
mortality of severely injured patients in 2012 with a decrease of 4.3% compared 
to 24.0% mortality in 1993 (TraumaRegister DGU(®) 2014). Thus, the overall 
mortality of severely injured patient in the European setting is ranging between 
17.2% and 26.2% (DiSaverio, et al. 2014, Heim, et al. 2014, Nijboer, et al. 2007, 
TraumaRegister DGU(®) 2014, Rauf, et al. 2019). 
Mean age is reported to range between 41 and 46 years and is increasing in 
time (Heim, et al. 2014, TraumaRegister DGU(®) 2014, Nijboer, et al. 2007). 
Most of the patients are male constituting over 70% of the cases in most of the 
investigations (TraumaRegister DGU(®) 2014, Heim, et al. 2014).  
 
 
2.3. Trauma Repositories 
2.3.1. Overview 
Trauma repositories are important tools for monitoring outcomes and demo-
graphics of injured patients with a possibility of extraction the data at any time 
point with large number of cases including many regions and hospitals (Moore ja 
Clark 2008). Thus, trauma registries permit to conduct large-scale studies with 
high number of variables with a relatively short accrual time and constitute an 
integral component of a developed trauma system. However, development and 
management of injury repositories require significant amount of investments, 
time, dedicated and motivated team, and data validation. There are gold standard 
trauma repositories globally and the following description is to provide baseline 
characteristics of the databases. 
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2.3.2. National Trauma Data Bank® 
NTDB® is the largest trauma registry involving a wide network of the American 
and Canadian trauma centers (NTDB® 1997). The NTDB establishment was 
initiated already in 1989 and the first call for data insertion was in 1997 (The 
American College of Surgeons 2019). Per the recent annual report, the NTDB® 
contains more than eight million patient records accrued from 765 separate 
trauma facilities (The American College of Surgeons 2018). The existence of 
such large and mature database provides an opportunity to review and validate 
both common and rare injuries using a large population (Aiolfi, et al. 2017, 
Englum, et al. 2016). A significant number of scientific reports are continuously 
published using the database. 
 
 
2.3.3. TraumaRegister DGU® 
DGU® was founded in 1993 with most participating hospitals located in Germany 
and more than 270 000 patients are inserted since the foundation (TraumaRegister 
DGU® 1993). Also, Belgium, Luxembourg, Finland, Austria, Netherlands, 
Switzerland, Slovenia and United Arab Emirates are contributing to DGU®. 
Overall, 675 hospitals are participating (AUC 2018). About 20 articles with large 
number of cases are published in accredited journals based on the DGU database 
annually.  
 
 
2.3.4. The Trauma Audit & Research Network (TARN) 
The TARN is the United Kingdom national trauma registry with mandatory data 
upload from all major trauma centers (Racy, Al-Nammari ja Hing 2014). The 
TARN was established in 1989 and consists over 200 000 cases with about 10% 
being pediatric patients (National Institute for Health and Care Excellence (UK) 
2016). Many important scientific reports in high impact journals are published 
utilizing the TARN registry (Edwards 2015). For example, a study by Patel et al. 
regarding head injuries published in the Lancet initiated improvements in the 
entire trauma system in the UK (Patel, et al. 2005).  
 
 
2.3.5. The Helsinki University Hospital trauma registry 
The nearest trauma center to Estonia with trauma registry is Helsinki University 
Hospital. HTR was established in 2005 and covers Southern Finland with an 
estimated population of two million inhabitants. The first benchmarking study 
for the HTR was published in 2008 with an outcome comparison with a sample 
population from the TARN database (Handolin, et al. 2008). 1635 and 15 269 
patients from the HTR and the TARN database were included, respectively, 
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showing better survival in the Helsinki University Hospital. Other more recent 
study comparing severely injured patients of the HTR with the DGU® registry 
reported similar outcomes with SMR of 0.79 and 0.82 in Southern Finland and at 
German hospitals, respectively (Brinck, et al. 2015).  
 
 
2.3.6. Estonian Trauma Repository 
Estonian trauma repository was initiated in 2015 including all severely injured 
patients admitted to the NEMC, TCH or TUH. The repository serves a popu-
lation-based perspective as all the trauma centers in Estonia is involved. The first 
investigation published utilizing the data extracted from the repository is the 
Paper IV of the current thesis. A second recently published study about the role 
of elevated cardiac troponin on outcomes following severe chest trauma was 
partially using the repositories data (Keskpaik, et al. 2019). Thus, with a short 
period of time the repository has already contributed significantly showing the 
importance of registries as a part of trauma system. 
 
 
2.3.7. Conclusion 
Trauma repositories are highly important instruments in trauma systems allowing 
continuous data feedback with short accrual time including pooled data. The 
largest and most accredited registry globally is NTDB®. TARN and DGU® are 
the largest repositories in the European setting contributing many significant 
reports annually. HTR in Finland is an ideal registry for benchmarking against 
our trauma system as the Finnish demographics and trauma profile is similar to 
Estonia.  
 
 
2.4. Autopsy studies 
Majority of the trauma-related studies are conducted on patients admitted to 
health-care facilities, however, most of the injury related deaths occur in pre-
hospital settings (Trunkey 1983). Thus, studies investigating population-based 
epidemiology of trauma deaths and injury-patterns are expected to include 
prehospital events and outcomes.  
One of the most accredited and cited autopsy studies published by Shackford 
and colleagues in 1993 included all non-thermal injury related deaths in San 
Diego County during one-year period (Shackford, et al. 1993). Overall, 623 
trauma victims were included in final analysis with most frequent cause of death 
being head injury at 40.3%, followed by hemorrhage at 30.5% and spinal cord 
injuries at 8.2% of the cases. Blunt and penetrating trauma accounted for 70.7% 
and 29.3% of the cases, respectively. Motor-vehicle accident was the pre-
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dominant mechanism of injury constituting 55% of the deaths. Mean age was 
36.4 years and 76.6% were male. Mean ISS was 49.7.  
In the European region, a study from the Thames region in London analyzed 
a total of 434 trauma deaths (Daly ja Thomas 1992). Motor vehicle accidents 
were the most frequent mechanism of injury, 59% of the deaths occurred in a pre-
hospital setting. Similarly, an investigation of 329 injury-related deaths in 
Diyarbakir city in Turkey also reported motor vehicle accidents as the most 
frequent mechanism of injury at 40% of the cases followed by falls from height 
at 33.7% (Yagmur, Kiraz ja Kara 1999). 69% were male. Another population-
based study investigating traumatic deaths in Shanghai included 10,135 victims 
with a mean age was 40.9 years and males constituted 66%. Most frequent 
mechanism was traffic accidents (He, et al. 2015).  
Hemorrhage is reported to be the second most common cause of death after 
head injuries with cardiac and aortic injuries predominating (Shackford, et al. 
1993). An investigation including blunt trauma fatalities in the Los Angeles 
County found that 32% of the victims suffered cardiac injury with right atrium 
and right ventricle being the most frequently injured chamber at 30% and 27%, 
respectively (Teixeira, et al. 2009). A large study by Campbell et al. including 
1,198 patients with penetrating cardiac injuries observed right ventricle as the 
most commonly injured cardiac chamber (Campbell , et al. 1997). A study by 
Shackelford et al. reported thoracic aortic injuries as the most frequent cause of 
death after train crash in Los Angeles County in 2011 (Shackelford, et al. 2011). 
In summary, severe head injuries are the leading cause of death after injury 
(Shackford, et al. 1993), about two-third of trauma victims cases are males 
(Shackford, et al. 1993, Yagmur, Kiraz ja Kara 1999, He, et al. 2015, Sharma, et 
al. 2006) and the most frequent mechanism of injury is traffic accidents 
(Shackford, et al. 1993, Daly ja Thomas 1992, Yagmur, Kiraz ja Kara 1999). 
However, actual population-based studies with detailed analysis of exact injuries 
are scarce and most of the regional investigations are extrapolated to population-
based estimates.  
 
 
2.5. Summary of the Literature 
The well-known classical trauma scores ISS, RTS and TRISS persist as the 
globally utilized standardized measures of injury severity. 
Mortality of severely injured patients (ISS >15) is significantly decreased 
when admitted to a designated Level I trauma center.  
Trauma repositories are important instruments in trauma systems allowing 
continuous data feedback with short accrual time and are integral part of modern 
trauma system.  
Most of the trauma related deaths occur in a pre-hospital setting. Traffic 
accidents are reported as predominating mechanism of injury. 
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3. AIMS OF THE STUDY 
The main purpose was to investigate demographics and outcomes of severely 
injured patients (ISS >15) in Estonia including comparison between Estonian 
trauma centers, between time periods of early and established independence, and 
with other trauma systems.  
 
The specific aims were: 
 
1.  To study outcomes of severely injured patients comparing Estonian trauma 
centers NEMC+TCH versus TUH (Paper I). 
 
2.  To compare demographic patterns and outcomes of severe trauma during early 
vs. established independence of Estonia (Paper II). 
 
3.  To assess mechanism of trauma, injury profile and detailed causes of death of 
all injury-related fatalities after blunt or penetrating trauma in Estonia (Paper 
III). 
 
4.  To benchmark demographics, management and outcomes of severely injured 
patients of the NEMC against Helsinki University Hospital using regional 
trauma repositories (Paper IV). 
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4. MATERIAL AND METHODS 
4.1. Inclusion and exclusion criteria (Papers I–IV) 
4.1.1. Paper I 
All consecutive trauma admissions with an ISS >15 to the NEMC+TCH and TUH 
between 1/1/2013 and 31/12/2013 were retrospectively reviewed. All age groups 
were involved. 
 
 
4.1.2. Paper II 
All adult patients (≥18 years) with an ISS >15 admitted to the NEMC or TUH 
between 1/1/1993 and 31/12/1994 versus 1/1/2013 and 31/12/2014 were 
retrospectively included. 
 
 
4.1.3. Paper III 
All consecutive autopsies after blunt or penetrating traumatic deaths between 
1/1/2009 and 31/12/2013 (5-year period) were retrospectively included utilizing 
the National Forensic Medicine Database. Fatalities related to suffocation, 
freezing, burns or intoxication were excluded. 
 
 
4.1.4. Paper IV 
All severely injured (ISS >15) patients from the TTR and HTR were reviewed. 
Patients <16 years, patients with penetrating injuries and transfers from other 
hospitals were excluded (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flowchart of all included patients (Paper IV). 
Included for analysis 
HTR 324 
TTR 152
Excluded 
1.  Age <16  
  HTR 1  
  TTR 5 
2.  Penetrating injuries  
  HTR 6 
  TTR 17 
3.  Transferred patients  
  HTR 121 
  TTR 24 
All recorded patients 
ISS >15; 1/1/2015-31/12/2016 
HTR 452  
TTR 198 
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4.2. Data collection 
Data collected included gender, age, mechanism of injury, vital signs, AIS-score, 
ISS, RTS, specific injuries, and cause of death (I–IV). TRISS score was calcu-
lated for the Paper I and IV. Data about complications per Clavien Dindo and 
HLOS were collected for the Paper I and II (Dindo, Demartines ja Clavien 2004). 
Data for Paper IV was extracted from the prospective databases (HTR and 
TTR) with both repositories following the Utstein criteria. The TTR covers 
Northern Estonia with estimated population of 800 000 and was initiated in 2015. 
The HTR was established in 2005 and is covering Southern Finland comprising 
a population of 2 million inhabitants.  
 
 
4.3. Statistical analysis 
The p-values for categorical variables were derived from the Chi-square test or 
2-sided Fisher’s test (Papers I–IV). Student’s t test or Mann-Whitney tests were 
utilized for continuous variables (Papers I–IV). P-value <0.05 was defined as 
statistically significant. Logistic regression analysis was used to compare defined 
outcomes adjusted for statistically significant (p-value <0.05) demographic 
variables and mechanism of injuries: 
 
• complications, in-hospital mortality, HLOS, ICU-LOS (Paper I) 
• complications, in-hospital mortality (Paper II) 
• 30-day mortality (Paper IV) 
 
Statistical analyses for Papers I–III were performed with the Statistical Package 
for Social Sciences (SPSS for Mac©), version 16.0 (SPSS Inc., Chicago, IL, 
USA) and for the Paper IV the R-program version 3.3.2 (R Foundation, Vienna, 
Austria) was utilized. 
Values are reported as mean ± standard deviation for continuous variables and 
as a percentage for categorical variables. 
 
 
4.4. Outcomes 
4.4.1. Paper I 
Primary outcome was in-hospital mortality. Secondary outcomes included HLOS 
and complications per Clavien-Dindo. All the outcomes were compared between 
Estonian trauma centers (NEMC+TCH vs. TUH). 
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4.4.2. Paper II 
Primary outcome was in-hospital mortality. Secondary outcomes were HLOS, 
complications per Clavien-Dindo, and incidence of penetrating trauma. All the 
outcomes were compared between the periods of early and established indepen-
dence (1993–1994 vs. 2013–2014). 
 
 
4.4.3. Paper III 
Primary outcome was cause of death. Secondary outcomes were injury patterns. 
 
 
4.4.4. Paper IV 
Primary outcomes were 30-day mortality and SMR per the TRISS score. 
Secondary outcomes included HLOS and ICU-LOS.  
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5. RESULTS 
5.1. Demographics and outcomes of severely injured 
patients in Estonia and comparison between trauma 
centers: North Estonia Medical Center + Tallinn Children’s 
Hospital versus Tartu University Hospital (Paper I) 
5.1.1. Demographics 
Overall, 256 severely injured patients were admitted to the Estonian major trauma 
centers during the study period (1/2013–12/2013): 142 and 114 to the NEMC+ 
TCH and TUH, respectively. Demographic profile is depicted in the Table 1. 
Patients admitted to the TUH were significantly older. Male patients predomi-
nated in both trauma centers. Overall, almost every second patient had a GCS 
below < 9. Significantly higher proportion of cases was hypotensive on admission 
to the NEMC. 
Most frequent mechanism of injury was ground level falls at 24.6% followed 
by non-ground level falls and auto versus pedestrian injuries constituting 19.6% 
and 10.5% of all admissions, respectively. Penetrating trauma accounted for 5.1% 
of cases (9.2% at the NEMC+TCH vs. 0% at the TUH, p=0.003). 
 
Table 1. Demographic profile of all patients. 
Characteristics Overall n=256 
NEMC+TCH 
n=142 
TUH 
n=114 p-value 
Age 47.2 ± 20.6 44.8 ± 21.4 50.3 ± 19.1 0.035 
Age ≥ 65 18.4% (47) 17.6% (25) 19.3% (22) 0.728 
Male 81.3% (208) 81.7% (116) 80.7% (92) 0.840 
CCI 0.35 ± 0.89 0.37 ± 0.90 0.34 ± 0.92 0.810 
GCS <9 44.1% (113) 46.5% (66) 41.2% (47) 0.400 
SBP <90 13.3% (34) 18.3% (26) 7.0% (8) 0.008 
 
 
5.1.2. Injury profile and severity 
Injury scorings and profile are shown in the Table 2. Mean ISS was similar 
between the trauma centers. A number of critically injured patients (ISS >25) 
were significantly higher at the NEMC. Severe chest, abdominal and extremity 
injuries were more frequent at the NEMC, however, the rate of severe head 
injuries was higher at the TUH. Expected mortality per the TRISS score was 
higher at the NEMC without reaching statistical significance. A trend towards 
lower RTS score was noted at the NEMC (p=0.161). 
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TBI was the most frequent type of severe injury (Table 2) with SDH 
constituting vast majority of TBI subtypes (Table 3). 
 
Table 2. Injury profile and scorings of all patients. 
Characteristics Overall n=256 
NEMC+TCH 
n=142 
TUH 
n=114 p-value  
AIS head ≥ 3 76.2% (195) 69.0% (98) 85.1% (97) 0.003 
AIS thorax ≥ 3 25.8% (66) 31.0% (44) 19.3% (22) 0.034 
AIS abdomen ≥ 3 10.9% (28) 14.8% (21) 6.1% (7) 0.028 
AIS extremity ≥ 3 13.7% (35) 18.3% (26) 7.9% (9) 0.016 
ISS 23.6 ± 7.8 23.7 ± 9.1 23.5 ± 6.1 0.835 
ISS >25 18.0% (46) 23.2% (33) 11.4% (13) 0.014 
RTS 6.2 ± 1.8 6.0 ± 1.8 6.3 ± 1.7 0.161 
TRISS 77.9 ± 25.3 77.0 ± 26.3 79.0 ± 24.0 0.525 
Expected mortality* 22.1% 23.0% 21.0% 0.789 
*100%-TRISS 
 
 
Table 3. TBI Subtypes 
TBI Subtypes Overall n=256 
NEMC+TCH 
n=142 
TUH 
n=114 p-value  
EDH 11.7% (30) 11.3% (16) 12.3% (14) 0.802 
SDH 59.8% (153) 50.0% (71) 71.9% (82) <0.001 
SAH 28.9% (74) 31.7% (45) 25.4% (29) 0.273 
IVH 5.1% (13) 8.5% (12) 0.9% (1) 0.006 
IPH 8.6% (22) 12.7% (18) 3.5% (4) 0.009 
 
 
5.1.3. Surgical interventions 
A total of 74.6% of the patients required surgery. Craniotomy was the most 
frequent surgical intervention performed in both centers (Table 4). 
A total of 3.9% of the patients required interventional radiology (4.9% at the 
NEMC+TCH vs. 2.6% at the TUH, p=0.519). 
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Table 4. Surgical interventions 
Surgical interventions Overall n=256 
NEMC+TCH
n=142 
TUH 
n=114 p-value  
Surgery 74.6% (191) 75.4% (107) 73.7% (84) 0.761 
Craniotomy/craniectomy 49.6% (127) 44.4% (63) 56.1% (64) 0.061 
 Laparotomy 6.6% (17) 8.5% (12) 4.4% (5) 0.194 
 Thoracotomy  2.3% (6) 2.8% (4) 1.8% (2) 0.695 
 Misscellaneous 16.0% (41) 19.7% (28) 11.4% (13) 0.071 
 
 
5.1.4. Outcomes 
The overall rate of complications was 40.2% and did not differ between the 
trauma centers (40.1% at the NEMC+TCH vs. 40.4% at the TUH, p=0.973). 
Grade II complications per Clavien-Dindo predominated with pneumonia being 
the most frequent adverse event. 
Mean HLOS was 15.9 ± 20.7 days being significantly higher at the NEMC+ 
TCH (20.1 ± 25.1 vs. 10.5 ± 11.2 days, p<0.001). ICU-LOS was 7.1 ± 10.6 and 
4.4 ± 5.8 days at the NEMC+TCH and TUH, respectively (p=0.019). Overall 
ICU-LOS was 5.9 ± 8.9 days. 
Overall mortality was 20.7%. Crude mortality was significantly higher at the 
NEMC+TCH (25.4% vs. 14.9%, p=0.04), however, adjusted mortality was similar 
in both trauma centers (p=0.393). Head injuries accounted for most of the deaths 
(Table 5). 
 
Table 5. Mortality and Causes of Death 
Characteristics Overall n=256 
NEMC+TCH
n=142 
TUH 
n=114 p-value 
Crude mortality 20.7% (53) 25.4% (36) 14.9% (17) 0.040 
*Adjusted mortality 
 
0.393 (OR 1.38, 
CI 0.66–2.92) 
Cerebral edema 73.6% (39/53) 66.7% (24/36) 88.2% (15/17) 0.180 
Hemorrhage 15.1% (8/53) 16.7% (6/36) 11.8% (2/17) 1.00 
Other causes of death 11.3% (6/53) 16.7% (6/36) 0% (0) 0.160 
*adjusted for age, ISS> 25, SBP<90 mmHg, AIS head and neck/ thorax / abdomen/ extremity ≥ 3, 
penetrating trauma, SDH, IVH, IPH 
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5.2. Evolution of severe trauma in Estonia comparing  
early versus established independence:  
1993–1994 versus 2013–2014 (Paper II) 
5.2.1. Demographics  
A total of 1064 cases were included, 593 cases from the period of early inde-
pendence (1993–1994) and 471 cases from the established independence period 
(2013–2014).  
Demographics and injury profile is depicted in the Table 5. A mean age of 
patients admitted during the early independence period was significantly lower. 
Every fifth patient was hemodynamically unstable during admission between 
1993–1994 being significantly higher compared to 13.0% during the established 
independence period (p=0.001). Prevalence of severe abdominal injuries was 
higher during early independence; however, severe extremity injuries were more 
frequent between 2013–2014. 
 
Table 5. Demographics and Injury Profile of All Patients 
Characteristics 1993–1994 n=593 
2013–2014 
n=471 p-value  
Age 43.0 ± 15.3 53.2 ± 17.5 <0.001 
Age > 65  7.8% (46) 25.1% (118) <0.001 
Male  85.8% (509) 78.1% (368) 0.001 
SBP < 90 mmHg  20.4% (121) 13.0% (61) 0.001 
GCS < 9  40.6% (241) 41.6% (196) 0.749 
ISS 23.7 ± 8.8 23.3 ± 7.6 0.730 
ISS > 25  19.7% (117) 16.6% (78) 0.184 
AIS head ≥ 3   81.3% (482) 79.2% (373) 0.394 
AIS thorax ≥ 3  20.2% (120) 21.7% (102) 0.571 
AIS abdomen ≥ 3  17.4% (103) 11.0% (52) 0.004 
AIS extremity ≥ 3  5.9% (35) 10.8% (51) 0.003 
 
 
5.2.2. Mechanism of injuries 
The rate of severe penetrating injuries was higher during the period of early 
independence (11.1% vs. 6.4%, p=0.007). The lower rate of penetrating trauma 
during the established independence period is mostly affected by significant 
decrease of gunshot wounds (Table 6). Also, prevalence of blunt assaults and 
motor vehicle crashes has decreased significantly (Table 6). The rate of ground 
level falls and bicycle crashes has increased in time (Table 6). 
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Table 6. Mechanism of injuries 
Mechanism of injuries 1993–1994 n=593 
2013–2014 
n=471 p-value  
Gunshot wounds 6.9% (41)  1.5% (7) <0.001 
Stab wounds  4.2% (25) 4.9% (23) 0.600 
Ground level falls  20.1% (119)  46.5% (219) <0.001 
Non-ground level falls 13.2% (78) 16.1% (76) 0.170 
Motor vehicle crashes 15.5% (92) 6.2% (29) <0.001 
Motorcycle crashes 2.7% (16) 1.9% (9) 0.400 
Bicycle crashes  1.7% (10) 4.0% (19) 0.020 
Auto vs. pedestrian  7.3% (43) 5.5% (26) 0.250 
Struck by falling object 2.0% (12) 1.3% (6) 0.350 
Hit, struck, kick by other person 14.7% (87) 7.4% (35) <0.001 
Other  11.8% (70) 4.7% (22) <0.001 
 
 
5.2.3. Surgical interventions 
The overall surgical activity was similar between the periods with a trend towards 
higher rate of operations during the early period (76.9% vs. 72.2%, p=0.079). The 
number of laparotomies was significantly higher during the early period (13.7% 
vs. 7.9%, p=0.003). The rate of thoracotomies (2.5% in the early period vs. 2.8% 
in the established period, p=0.815), craniotomies (53.0% in the early period vs. 
50.7% in the established period, p=0.474) and other surgical procedures were 
similar.  
 
 
5.2.4. Specific injuries 
All the specific injuries are shown in the Table 7. There were no IVC-injuries 
during the established period compared to 12 cases in the early period. SDH and 
SAH rate was significantly higher during the established period, however, IPH 
and IVH rate was higher in the early period. Overall, only one esophageal injury 
was diagnosed between 2013–2014. 
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Table 7. Specific Injuries of all patients 
Characteristics 1993–1994 n=593 
2013–2014 
n=471 p-value  
Traumatic brain injury    
EDH  14.5% (86) 12.3% (58) 0.300 
SDH  41.3% (245) 63.3% (298) <0.001 
IPH  16.7% (99) 10.6% (50) 0.005 
SAH  14.8% (88)  25.1% (118) <0.001 
IVH  8.8% (52) 4.7% (22) 0.009 
Cardiac injuries 1.9% (11) 1.1% (5) 0.291 
Lung injuries 7.9% (47) 10.4% (49) 0.161 
Tracheal injuries 0.7% (4) 0 0.096 
Esophageal injuries 0 0.2% (1) 0.443 
Aortic injuries 1.9% (11) 1.1% (5) 0.291 
Vena cava injuries 2.0% (12) 0 0.002 
Diaphragmatic injuries 1.7% (10) 1.3% (6) 0.583 
Liver injuries 6.9% (41) 4.7% (22) 0.124 
Splenic injuries 5.1% (30) 4.7% (22) 0.771 
Renal injuries 3.2% (19) 2.6% (12) 0.527 
 
 
5.2.5. Outcomes 
Overall complication rate was 42.2% and 35.2% during the early and established 
period, respectively (p=0.022). HLOS was similar between the periods (15.4 ± 
19.0 vs. 15.7 ± 20.9 days, p=0.920).  
Crude and adjusted mortality was significantly higher during the early period 
(Table 8). Every second patient admitted during the early period deceased with 
crude mortality rate of 50.3%. Most common cause of death in both periods was 
TBI. 
 
  
28 
Table 8. Crude and adjusted mortality and causes of death. 
Characteristics 1993–1994 n=593 
2013–2014 
n=471 p-value OR (95% CI) 
Crude mortality  50.3% (298) 16.4% (77) <0.001  
*Adjusted Mortality   <0.001 7.01 (4.69–10.47) 
TBI 61.7% (184/298) 80.5% (62/77) 0.002  
Hemorrhage  15.4% (46/298) 7.8% (6/77) 0.080  
Septic complications  18.1% (54/298) 9.1% (7/77) 0.056  
Other  4.7% (14/298) 2.6% (2/77) 0.420  
*Adjusted for age, gender, hypotension on admission (SBP <90mmHg), AIS ≥ 3 for abdomen and 
extremity, mechanism of injuries, laparotomy, different TBI subtypes, and vena cava injuries 
 
 
5.3. Population-based autopsy study of traumatic  
fatalities (Paper III) 
5.3.1. Demographics  
During the 5-year study period, 1344 cases were included. Blunt and penetrating 
injuries constituted 75.7% and 24.3% of autopsies, respectively. Pre-hospital and 
in-hospital deaths accounted for 71.8% and 28.2% of the cases, respectively (p 
<0.05). All the demographic data is represented in the Table 9. Most of the 
traumatic deaths were related to male patients being significantly higher in the 
penetrating trauma subgroup (p=0.002). Overall, more than half of the victims 
had a positive blood alcohol level (51.1%) and almost every tenth patient resulted 
positive at drug screening (8.3%).  
 
Table 9. Demographics of all cases. 
 
Characteristics 
Total 
n=1344 
100.0% 
Blunt 
n=1018 
75.7% 
Penetrating 
n=326  
24.3% 
 
p-value 
Age 50.4 ± 18.5 51.0 ± 19.2 48.5 ± 16.0 0.034 
Age >65 22.1% 24.5% 14.7% <0.001 
Age <18 2.4% 3.0% 0.6% 0.016 
Male 77.1% 75.0% 83.4% 0.002 
Accident 64.4% 83.7% 4.0% <0.001 
Assault 20.5% 10.6% 51.2% <0.001 
Suicide 15.2% 5.7% 44.8% <0.001 
Blood alcohol level + 51.1% 47.2% 61.2% <0.001 
Drugs + 8.3% 8.5% 7.8% 0.874 
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5.3.2. Mechanism of injuries 
Most frequent mechanism of injury was motor vehicle accident constituting 
18.7% of all deaths followed by non-ground level falls and ground level falls at 
14.7 and 14.0%, respectively (Table 10). 
 
Table 10. Mechanism of injury. 
Mechanism of injury 
Overall  
n = 1344  
(100.0%) 
 Motor vehicle accident 18.7%  
 Non-ground level fall 14.7%  
 Ground level fall 14.0%  
 Sharp object 13.1% 
 Gunshot wound 11.2%  
 Auto vs. Pedestrian 11.1%  
 Hit, struck or kick by other person 8.0%  
 Bicycle accident 3.0%  
 Motorcycle accident 1.5%  
 Other or unknown 4.7% 
 
 
5.3.3. Abbreviated Injury Scale and Injury Severity Score  
Overall mean ISS was 39.7 and significantly higher in the penetrating trauma 
group at 47.7 (p<0.001). A total of three out of four patients had a severe head 
injury and almost half of the patients had severe chest injuries (Table 11). 
 
Table 11. ISS and AIS of all autopsies. 
 
Characteristics 
Total 
n=1344 
100.0% 
Blunt 
n=1018  
75.7% 
Penetrating 
n=326  
24.3% 
 
p-value 
ISS 39.7 ± 23.9 37.1 ± 22.0 47.7 ± 27.8 <0.001 
AIS head/neck ≥3 74.9% 82.2% 51.8% <0.001 
AIS chest ≥3 46.4% 48.3% 40.2% 0.010 
AIS abdomen ≥3 24.5% 27.3% 15.6% <0.001 
AIS extremity ≥3 19.9% 24.0% 7.4% <0.001 
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5.3.4. Primary outcome: Causes of death 
Most frequent cause of death was head injury at 50.5% followed by hemorrhage 
and multiple lethal injuries constituting 30.4% and 10.9% of all deaths. Other less 
frequent causes were cardiopulmonary failure (4.4%), spinal cord injury (2.2%) 
and sepsis/ multi-organ failure/ pneumonia (1.6%) (Figure 3).  
 
 
Figure 3. Causes of death. 
 
 
5.3.5. Secondary outcome: Injury patterns 
A total of 29.4% of the patients had a skull fracture. Most frequent type of intra-
cranial bleeding was SAH at 44.5% followed by SDH (27.8%) and IVH (10.6%). 
Overall, 10.9% (n=147) and 10.9% of the patients had cardiac injuries and 
aortic injuries, respectively. The most frequently injured chamber was right 
ventricle followed by left ventricle (Figure 4).  
 
 
 
 
Figure 4. Cardiac injuries. 
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Most frequent intra-abdominal solid organ injury was liver injury at 21.7%. 
Splenic and renal injuries were encountered at 12.3 and 6.4% of the cases, 
respectively. 
 
 
5.4. Severe blunt trauma in Finland and Estonia: 
comparison of two regional trauma repositories  
5.4.1. Demographic profile 
All the demographic profile is showed in the Table 12. No statistically significant 
differences were noted. A high proportion of patients older than 65 years are 
admitted in both institutions. 
 
Table 12. Demographic profile of all patients. 
Characteristics TTR n=152 
HTR 
n=324 p-value 
Age (years) 47.7 ± 19.2 48.4 ± 20.1 0.694 
Age >65 years 19.7% (30) 23.5% (76) 0.429 
Male 73.7% (112) 72.5% (235) 0.878 
GCS < 9 28.3% (43) 33.6% (109) 0.288 
SBP < 90 mmHg 12.5% (19) 9.0% (29) 0.300 
 
 
5.4.2. Abbreviated Injury Scale and Injury Severity Score 
Mean ISS was similar in both regions (p=0.678). Significantly higher proportion 
of patients with severe abdominal injuries was admitted in Northern Estonia 
compared to Southern Finland (p=0.002). A trend towards higher rate of severe 
chest injuries in Southern Finland was noted (p=0.112) (Table 13). 
 
Table 13. ISS and AIS of all patients. 
Characteristics TTR n=152 
HTR 
n=324 p-value 
ISS 25.7 ± 10.1 26.1 ± 9.7  0.678 
AIS head ≥ 3 56.6% (86) 61.4% (199) 0.366 
AIS chest ≥ 3 52.0% (79) 60.2% (195) 0.112 
AIS abdomen ≥ 3 25.0% (38) 13.3% (43) 0.002 
AIS extremity ≥ 3 27.6% (42) 31.5% (102) 0.456 
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5.4.3. Mechanism of injuries  
Non-ground level fall was predominant mechanism of injury in both regions 
followed by motor vehicle accidents. The rate of non-ground level falls is 
significantly higher in the Northern Estonia (p=0.046). Patients injured in bicycle 
accidents are more frequent in the Southern Finland region (p=0.008).  
 
Table 14. Mechanism of injuries. 
Mechanism of injuries TTR n=152 
HTR 
n=324 p-value 
Non-ground level fall 32.9% (50) 23.8% (77) 0.046 
Motor vehicle accident 17.1% (26)  15.1% (49) 0.676 
Ground level fall 11.8% (18) 15.1% (49) 0.413 
Auto vs. pedestrian 11.2% (17) 5.9% (19) 0.063 
Motorcycle accident 8.6% (13) 12.0% (39) 0.328 
Bicycle accident 3.9% (6) 12.0% (39) 0.008 
Other or unknown 14.5% (22) 16.0% (52) 0.759 
 
 
5.4.4. Outcomes 
Mean HLOS was 26.3 ± 36.1 and 12.4 ± 10.3 in TTR and HTR, respectively 
(p=0.003). Mean ICU-LOS was 14.3 ± 17.5 and 8.5 ± 7.3 in TTR and HTR, 
respectively (p=0.044), however, ventilation days were similar (10.7 ± 15.3 in 
TTR vs. 6.6 ± 6.3 in HTR, p=0.288). 
Primary outcomes are represented in the Table 15. Crude and adjusted 
mortality were similar between the regions. Both hospitals showed lower 
mortality compared to expected mortality per TRISS.  
Step-down hospital as a discharge destination was more frequently utilized at 
the Helsinki University Hospital (58.0% vs. 18.1%, p<0.001), however, home 
more frequently at the NEMC (50.7% vs. 20.7%, p<0.001). Also, a higher rate of 
patients was discharged to rehabilitation from the NEMC (16.4% vs. 6.2%, 
p<0.001). 
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Table 15. TRISS, SMR and 30-day mortality of all patients. 
Characteristics TTR 
n=152 
HTR 
n=324 
p-value 
TRISS 81.1 ± 26.2 79.2 ± 25.5  
Expected mortalitya 18.9% 20.8%  
30-day in-hospital crude mortality 14.5%  13.6%  0.904 
30-day adjusted mortalityb   0.762  
Differencec (SMRd) –4.4% (0.77) –7.2% (0.65) >0.05 
a100.0%-TRISS 
badjusted for AIS abdomen ≥ 3, bicycle accident, non-ground level falls 
c30-day crude (observed) mortality–Expected mortality 
d30-day crude (observed) mortality/Expected mortality 
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6. DISCUSSION 
Severe injuries are significant public health concern globally and in Estonia 
constituting high proportion of all causes of death and morbidity. Nevertheless, 
studies focusing on severe trauma in Estonia are scarce. Thus, the current thesis 
investigates comprehensively severe injuries in Estonia including different time 
segments, trauma centers, pre- and in-hospital trauma deaths and comparisons 
with other trauma systems. 
The first study investigating severely injured patients admitted between 
1/2013 and 12/2013 to the Estonian trauma centers found overall crude mortality 
of 20.7% being similar to other European trauma centers reporting overall 
mortality ranging from 17.2% to 26.2% (DiSaverio, et al. 2014, Nijboer, et al. 
2007, TraumaRegister DGU(®) 2014, Rauf, et al. 2019) (Paper I). However, a 
study including 45 Level I trauma centers in USA reported overall mortality of 
14.9% for severely injured patients being lower compared to Estonian and 
European settings (Demetriades, et al. 2006). Thus, the mortality was acceptable 
in 2013, however, with significant potential for improvements.  
Nevertheless, the overall in-hospital mortality during the early independence 
period was devastating being 50.3% between 1993 and 1994 showing notable 
improvements in the management of trauma patients during the following 
decades (Paper II). Also, other regions in Europe have noted decreased mortality 
of severely injured patients in time, however, not so drastically. The largest trauma 
registry in the European region DGU® reported 4.3% decrease of mortality from 
24.0% in 1993 to 19.7% in 2012 (TraumaRegister DGU(®) 2014).  
A very high mortality during nineties is certainly multifactorial and may reflect 
a poor state of trauma system at that time in Estonia. Advancements in pre-hospital 
care and system, introduction of damage control resuscitation and surgery, trauma 
team activation criteria, evidence-based guidelines and management, better 
medical equipment, prompt availability and accessibility of radiological investi-
gations, evolved surgical critical care and rehabilitation have all contributed to 
the evolution of management of severely injured patients with significantly 
improved outcomes.  
Nevertheless, as previously mentioned, a room for improvements existed. The 
ATLS course as a baseline “Gold Standard” trauma course was introduced in 
2015 (American College of Surgeons 1980). Also, an active research involving 
trauma patients was initiated and since 2015 a prospective trauma repository 
exists in Estonia. A study extracting data from trauma repositories comparing out-
comes of severely injured patients admitted to the NEMC versus to the Helsinki 
University Hospital between 1/2015 and 12/2016 showed similar crude and 
adjusted mortality in both regions (Paper IV). Overall 30-day mortality at the 
NEMC was 14.5% being significantly lower compared to the expected mortality 
per TRISS methodology (Paper IV). Thus, it is prudent to speculate that the 
improved outcomes may be result of recent reforms and developments within the 
Estonian trauma system. Also, as demographic profile in Finland is very similar 
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to Estonia it is an ideal population for comparison and benchmarking. Thus, since 
Estonia regained independence in 1991, the evolution of the trauma system has 
been remarkable with improved trauma outcomes involving very different 
periods of time and confirming that the system is evolving significantly. 
The Estonian trauma centers showed similar adjusted primary outcomes 
(Paper I). The NEMC admitted significantly higher rate of patients with unstable 
hemodynamics (SBP <90mmHg), with severe chest, abdominal and extremity 
injuries and critical injury burden (ISS >25) explaining the higher crude mortality. 
However, after adjustment, the mortality did not differ between the major Estonian 
trauma facilities (p=0.393). Thus, the NEMC cares for higher rate of complex 
and critical patients. The higher proportion of critically injured patients also 
explains significantly longer HLOS at the NEMC. Head injuries were the primary 
cause of death in both trauma centers.  
Blunt trauma accounts for 91.2 to 97.1% of all severe trauma cases reported 
by different European institutes (Heim, et al. 2014, DiSaverio, et al. 2014, 
TraumaRegister DGU(®) 2014). Demographic profile in Estonia is typical for 
European setting with blunt injuries predominating. Non-ground level falls was 
the predominating mechanism between 1/2015 and 1/2016 similarly to Finland 
constituting almost third of all the injury mechanism (Paper IV). Ground level 
falls was the most frequent mechanism of injury in 2013 followed by non-ground 
level falls (Paper I). Overall severe penetrating trauma rate have been below 10% 
in recent years (Paper I, II). Nevertheless, penetrating trauma mechanisms were 
significantly higher during nineties constituting 11.1% of all severe trauma cases, 
being remarkably high for an European setting (Paper II), thus, being similar to 
USA trauma population reporting 11.2% of severe penetrating trauma admissions 
(Demetriades, et al. 2006). Lack of effective gun control, fragmented law-enfor-
cement capabilities, relatively low overall income, high rate of organized crime 
and interpersonal violence were all contributing to the high rate of penetrating 
trauma in Estonia during nineties. The National Institute for Health Development 
reported 27.6 homicides per 100 000 in Estonia between 1993–1994, thus, if the 
violent death rate would be similar at the present time Estonia would be in the 
top 20 of most violent countries in the world (UNODC Statistics Online 2018, 
The National Institute of Health Development 2015). Fortunately, the inter-
personal violence and criminal activity has decreased significantly with homicide 
rate of 2.2 per 100 000 in 2017 placing Estonia to the 140th position between all 
the countries (UNODC Statistics Online 2018). A significantly lower rate of gun-
shot wounds has the highest impact for overall decrease of penetrating injuries 
(Paper II). Possible causes are overall economic improvement, strict gun-control 
legislation and improved law-enforcement capabilities (Riigi Teataja 2001). 
Thus, even with a high trauma caseload during nineties, injury outcomes were 
detrimental due to a lack of proper trauma system and non-existing continuous 
trauma education. 
The population-based autopsy study including all traumatic deaths after pene-
trating or blunt injuries in Estonia is a pioneering study involving the entire 
Estonian population instead of extrapolating to population-based estimates 
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(Paper III). Also, autopsy studies include pre-hospital deaths offering information 
about cases, which are usually excluded in most studies and involving in-hospital 
deaths only. Our study showed that more than two third of deaths occurred in a 
pre-hospital setting, thus, proving again that with effective injury prevention, 
many lives could have been saved.  
Similar to other reports, MVA was the most frequent cause of death in Estonia 
(Shackford, et al. 1993, Daly ja Thomas 1992, Yagmur, Kiraz ja Kara 1999). 
Traffic accidents are among top ten leading causes of death in the world per the 
recent WHO report and with possible increase during next decades (WHO 2008). 
Highly disturbing notion was in our study that more than half of the trauma 
victims had a positive blood alcohol level at the time of death and the rate was 
even higher in victims succumbing in penetrating injuries (Paper III). Estonian 
public alcohol-prevention measures have been more or less aggressive in recent 
years with raised excise duty on alcohol, time restrictions for alcohol sale, 
frequent alcohol breath tests for drivers, strict rules for alcohol advertisement and 
national campaigns about alcohol harm resulting in a lowest alcohol consumption 
per person during last decade in 2019 (National Institute for Health Development 
2019, Ministry of Social Affairs 2019). Nevertheless, alcohol abuse is still a 
significant problem in Estonia and active continuous national initiative for 
alcohol harm-reduction is of paramount important in Estonian society.  
Overall, head injuries were the leading cause of death constituting 50.5% of 
all cases followed by hemorrhage at 30.4% (Paper III). A study by Shackford et 
al. reported similar results with head injuries and hemorrhage related deaths 
constituting 40.3% and 30.5% of all cases, respectively (Shackford, et al. 1993). 
Thus, head injuries are the predominant cause of death in both pre-hospital and 
in-hospital setting irrespective of the region.  
A large proportion of patients (10.9%) had a cardiac injury at the moment of 
death with a right ventricle being the most frequently injured chamber overall 
(Paper III). Thus, if we include deceased patients only the number of cardiac 
injuries is surprisingly high. A large study by Teixeira and colleagues found that 
right cardiac chambers were the most frequently injured after blunt trauma with 
right atrium being most frequently injured followed by right ventricle (Teixeira, 
et al. 2009). However, in our study right ventricle was the most frequently injured 
chamber followed by left ventricle after blunt trauma. In a study by Campbell et 
al. right ventricle injuries were most frequent followed by left ventricle after 
penetrating trauma (Campbell , et al. 1997). Left ventricle was the most 
frequently injured chamber in our study followed by right ventricle in case of 
penetrating trauma.  
The limitations of the current thesis include retrospective nature of the 
publications I–III and rather low number of patients in the publications I and IV. 
Nevertheless, these are very first studies investigating comprehensively severely 
injured patients in Estonia with evolving trauma system. The studies showed 
comprehensively the overall evolution and state of Estonian trauma system with 
very important input for future improvements. 
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7. CONCLUSIONS 
1. Outcomes of severely injured patients were similar between the Estonian 
trauma centers. 
 
2.  Estonian trauma system has evolved significantly from early independence to 
established independence. 
 
3.  Head injuries were the predominating cause of death in the pre-hospital and 
in-hospital setting followed by hemorrhage related deaths. 
 
4.  Most of the injury related deaths occurred in a pre-hospital setting showing 
the importance of prevention. 
 
5.  MVA was the leading mechanism of injury after traumatic deaths. 
 
6.  High rate of patients with positive BAL after traumatic deaths warrants 
continuous national preventive measures. 
 
7.  The benchmarking study comparing outcomes of severely injured patients 
with the Helsinki University Hospital showed similar adjusted mortality. 
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8. SUMMARY IN ESTONIAN 
Raske trauma epidemioloogia Eestis 
8.1. Sissejuhatus 
Vigastussurmade tõttu kaotatud eluaastate hulk on suurem kui kasvajate ja 
südamehaiguste tõttu kaotatud eluaastate hulk kokku (Trunkey 1983). WHO 
andmetel hukkub trauma tõttu maailmas keegi iga kuue sekundi järel (WHO 
2015). Vigastussurmade osakaal Eestis on üks Euroopa Liidu kõrgemaid 
(EuroSafe 2013, EuroSafe 2014, EuroSafe 2016). Seega on traumaatilised 
vigastused märkimisväärne probleem nii globaalselt kui regionaalselt Eestis. 
Raske trauma on defineeritud kui ISS >15 ja on näidatud, et sellise vigastus-
koormusega patsientide elulemus on oluliselt parem, kui suunamine on koheselt 
kõrgema astme traumakeskusesse, mida Eestis esindavad Põhja-Eesti Regio-
naalhaigla (PERH) ja Tartu Ülikooli Kliinikum (TÜK) (Demetriades, et al. 2006, 
Baker, et al. 1974). Eestis puudusid varasemalt raskele traumale fokusseeritud 
uuringud ning antud käsikirja eesmärgiks on põhjalikult uurida antud haigete 
demograafilisi andmeid ja tulemeid Eestis. 
 
 
8.2. Eesmärgid 
Peamiseks eesmärgiks oli hinnata raskelt vigastatute (ISS >15) demograafiat ja 
käsitluse tulemeid Eestis. Täpsemad eesmärgid olid: 
 
1.  Võrrelda raskelt vigastatute tulemeid PERH-i ja TÜK-i vahel. 
2.  Võrrelda raskelt vigastatud haigete demograafiat ja tulemeid erinevatel 
ajaperioodidel (1993–1994 vs. 2013–2014) taasiseseisvunud Eestis. 
3.  Hinnata traumamehhanisme, vigastusmustreid ja täpseid surmapõhjuseid 
kõikidel tömbi või penetreeriva trauma tõttu hukkunutel. 
4.  Võrrelda raskelt vigastatute tulemeid PERH-is, Eesti suurimas trauma-
keskuses, Helsingi Ülikooli haigla traumakeskusega. 
 
 
8.3. Uuritavad ja meetodid 
Esimesse uuringusse kaasati retrospektiivselt kõik raske traumaga (ISS >15) 
patsiendid, kes hospitaliseeriti PERH-i ja Tallinna Lastehaiglasse (TLH) või 
TÜK-i ajavahemikul 1/1/2013 kuni 31/12/2013.  
Teise uuringusse kaasati retrospektiivselt kõik raskelt vigastatud haiged, kes 
hospitaliseeriti TÜK-i või PERH-i ajavahemikul 1/1/1993–31/12/1994 (varane 
periood) ja 1/1/2013–31/12/2014 (hilisem periood).  
Kolmandasse uuringusse kaasati retrospektiivselt kõik tömbi või läbiva vigas-
tuse tõttu surnud patsiendid Eestis ajavahemikul 1/1/2009 kuni 31/12/2013, kasu-
tades kõigi nelja Eesti kohtuarstliku keskuse lahanguandmeid. 
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Neljandas uuringus võrreldi PERH-i traumakogumi ja Helsingi Ülikooli 
haigla traumakogumi alusel raskelt vigastatud (ISS >15) haigete tulemeid. 
Statistilisel analüüsimisel kasutati pidevate andmete võrdlemisel Student  
t-test-i või Mann-Whitney testi ja kategoriseeritavate andmete võrdlemisel kasu-
tati hii-ruut testi või Fischer’i testi. Kohandatud tulemite võrdlemisel rakendati 
vajadusel logistilist regressioon analüüsi.  
 
 
8.4. Tulemused 
Esimesse uuringusse kaasati 256 vigastatut üldsuremusega 20.7%. Peamine 
surmapõhjus oli ajuvigastus. Kohandatud suremus oli traumakeskuste vahel 
sarnane (adj. p=0.393). Haiglas viibimise aeg oli PERH-is oluliselt pikem, mis 
on ilmselt mõjutatud suuremast hulgast kriitiliselt vigastatud haigetest PERH-is. 
Teise uuringusse kaasati 1064 patsienti, 593 patsienti varasest perioodist ja 
471 hilisemast perioodist. Oluliselt on vähenenud penetreerivate vigastuste hulk 
ja seda eelkõige laskevigastuste arvelt. Komplikatsioonide hulk haiglasoleku ajal 
oli varases perioodis oluliselt kõrgem (42.2% vs. 35.2%, p= 0.022). Drastiliselt 
on vähenenud raskelt vigastatute suremus, mis oli varases perioodis 50.3% ja 
16.4% hilisemas perioodis (adj. p<0.001). Mõlemas perioodis oli peamine 
surmapõhjus ajuvigastus. 
Kolmas uuring kaasas 1344 tömbi või läbiva vigastuse tõttu surnut. Tömbid 
ja läbivad vigastused moodustasid vastavalt 75.7% ja 24.3%. Enamus surmadest 
toimus haiglaeelselt (71.8%). Peamine mehhanism oli autoõnnetus. Surma hetkel 
esines alkoholijoove 51.1%-l hukkunutest. Peamine surmapõhjus oli peavigastus, 
moodustades 50.5% surmadest, millele järgnes veritsussurm 30.4%-ga.  
Neljas uuring kaasas 152 juhtu PERH-ist ja 324 juhtu Helsingi Ülikooli haig-
last. Demograafiline profiil oli haiglate vahel suhteliselt sarnane. Nii üldsuremus 
kui kohandatud suremus oli haiglate vahel sarnane. Mõlemad haiglad näitasid 
paremaid tulemeid, kui oli oodatav suremus TRISS alusel. 
 
 
8.5. Järeldused 
1. Eesti traumakeskuste tulemid raskelt vigastatud haigete käsitlemisel olid 
sarnased. 
2.  Raske traumaga haigete suremus on ajas oluliselt langenud. 
3.  Peamine surmapõhjus oli ajuvigastus nii haiglaeelselt kui haiglas surnutel. 
4.  Mootorsõiduki õnnetus oli peamine mehhanism vigastussurma korral. 
5.  Enamus vigastussurmasid toimus haiglaeelses etapis. 
6.  Väga suurel hulgal (51%) vigastustesse surnutel esines alkoholijoove. 
7.  PERH-i kui Eesti suurima traumakeskuse tulemid olid sarnased Helsingi 
Ülikooli haiglaga.  
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